Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of fluid resuscitation on pulmonary edema measured by alveolar clearance in ARDS patients
2010-024549-65Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hetastarch and sodium chloride in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Alveolar fluid clearance at 1 hour after vascular fluid loading. Started Feb 2011; status: active.
02
Drugs
hetastarchsodium chloride
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2010-024549-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024549-65.